Veronique Barragan-Montero

Dr. Veronique Barragan-Montero


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 June 2011 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
Lenaic LartigueLenaic Lartigue
Lenaic Lartigue
CICaludia Innocenti
Caludia Innocenti
TKThangavel Kalaivani
Thangavel Kalaivani
AAAzzam Awwad
Azzam Awwad
MDMaria del Mar Sanchez Duque
Maria del Mar Sanchez Duque
CSClaudio Sangregorio
Claudio Sangregorio

17 January 2014 in Molecules
Verified
Journal Article
Open access
PDF file
SCStéphanie Combemale
Stéphanie Combemale
JAJean-Norbert Assam-Evoung
Jean-Norbert Assam-Evoung
SHSabrina Houaidji
Sabrina Houaidji
RBRashda Bibi
Rashda Bibi
VBVeronique Barragan-Montero
Veronique Barragan-Montero
Herein, the preparation of neoglycoconjugates bearing mannose-6-phosphate analogues is described by: (a) synthesis of a cyclic sulfate precursor to access the carbohydrate head-group by nucleophilic displacement with an appropriate nucleophile; (b) introduction of spacers on the mannose-6-phosphate analogues via Huisgen’s cycloaddition, the Julia reaction, or the thiol-ene reaction under ultrasound activation. With the resulting compounds in hand, gold nanoparticles could be functionalized with various carbohydrate derivatives (glycoconjugates) and then tested for angiogenic activity. It was observed that the length and flexibility of the spacer separating the sugar analogue from the nanoparticle have little influence on the biological response. One particular nanoparticle system substantially inhibits blood vessel growth in contrast to activation by the corresponding monomeric glycoconjugate, thereby demonstrating the importance of multivalency in angiogenic activity.

6 July 2022 in Medicina
Verified
Journal Article
Open access
PDF file
CICătălina Ionescu
Cătălina Ionescu
BOBogdan Oprea
Bogdan Oprea
GCGeorgeta Ciobanu
Georgeta Ciobanu
MGMilena Georgescu
Milena Georgescu
RBRamona Bică
Ramona Bică
VBVeronique Barragan-Montero
Veronique Barragan-Montero
Angiogenesis is the process of developing new blood vessels from pre-existing ones. This review summarizes the main features of physiological and pathological angiogenesis and those of angiogenesis activation and inhibition. In healthy adults, angiogenesis is absent apart from its involvement in female reproductive functions and tissue regeneration. Angiogenesis is a complex process regulated by the action of specific activators and inhibitors. In certain diseases, modulating the angiogenic balance can be a therapeutic route, either by inhibiting angiogenesis (for example in the case of tumor angiogenesis), or by trying to activate the process of new blood vessels formation, which is the goal in case of cardiac or peripheral ischemia.

26 July 2011 in ChemMedChem
Verified
Journal Article
Closed access
PDF file
VBVeronique Barragan-Montero
Veronique Barragan-Montero
AAAzzam Awwad
Azzam Awwad
SCStéphanie Combemale
Stéphanie Combemale
PBPascal de Santa Barbara
Pascal de Santa Barbara
BJBernard Jover
Bernard Jover
JMJean‐Louis Montero
Jean‐Louis Montero

1 March 2015 in Tetrahedron
Verified
Journal Article
Closed access
AMApril L. Marquick
April L. Marquick
JMJean-Louis Montero
Jean-Louis Montero
ALAurelien Lebrun
Aurelien Lebrun
VBVeronique Barragan-Montero
Veronique Barragan-Montero

4 February 2026 in Biomimetics
Verified
Journal Article
Open access
PDF file
Pierre-Yves Collart-DutilleulPierre-Yves Collart-Dutilleul
Pierre-Yves Collart-Dutilleul
NFNaveen FATIMA
Naveen FATIMA
RYRichard Younes
Richard Younes
FCFrédéric Cuisinier
Frédéric Cuisinier
VBVeronique Barragan-Montero
Veronique Barragan-Montero
ADAlban Desoutter
Alban Desoutter
Bone regeneration in critical-size defects requires biomaterials that provide both structural support and appropriate osteoinductive cues. Natural nacre contains an organic matrix rich in acidic macromolecules with reported osteogenic activity; however, its in vivo regenerative potential remains insufficiently explored. This study evaluated the bone regenerative capacity of nacre-derived materials alone and combined with oxidized porous silicon microparticles (pSi-MP), a bioactive material known to release silicic acid and support mineralized tissue formation. Critical-size defects were created in four caudal vertebrae of Wistar rats and filled with nacre, pSi-MP, a nacre–pSi composite, or left empty. After 60 days, bone formation was assessed using micro-computed tomography and non-decalcified histology. Empty defects failed to regenerate, whereas nacre and pSi-MP individually promoted partial mineralized tissue deposition. The nacre–pSi composite produced the most extensive repair, showing near-complete defect bridging, higher bone mineral density, and seamless integration of particles within newly formed bone. No inflammation or adverse reactions were observed, and osteoid deposition occurred directly on material surfaces. These findings demonstrate that nacre-derived materials exert intrinsic osteogenic effects in vivo and that combining nacre with porous silicon yields a synergistic response that significantly enhances bone regeneration. The composite represents a promising candidate for future bone repair strategies.